Lv2
168 积分 2025-12-31 加入
Dose optimization of sotorasib: has the burden of proof for the labeled dose been met?
12小时前
待确认
The Retrofit: Lessons From Sotorasib's Dosing Conundrum
12小时前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
2天前
已完结
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer
2个月前
已完结
Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression
6个月前
已完结
Understanding XPO1 Target Networks Using Systems Biology and Mathematical Modeling
9个月前
已完结
皖公网安备34019202002308
